Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-01

FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved Hospira's supplemental application for testosterone cypionate, a generic testosterone replacement therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone cypionate (testosterone cypionate)

Snippet

SUPPL AP for TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)